Cáncer de tiroides en Chile. Estudio descriptivo sobre tasa de egreso hospitalario por cáncer de tiroides entre 2020-2023
Thyroid cancer in Chile. Descriptive study on hospital discharge rates for thyroid cancer between 2020 and 2023
DOI:
https://doi.org/10.56754/0718-9958.2025.268Keywords:
Hospitalización, Cáncer, Tiroides, Chile, EpidemiologíaAbstract
Abstracts:
Introduction: Thyroid cancer (TC) is the most frequent endocrine neoplasia, due to the lack of updated national data, we propose as objective to describe the hospital discharge rate (HDR) for thyroid cancer during the period 2020 to 2023 in Chile.
Materials and methods: Observational, descriptive and cross-sectional study. We performed a descriptive analysis of HDR by TC in the total population during the period 2020 - 2023 in Chile, according to the variables sex, age and length of hospital stay. Data were collected from the Department of Statistics and Health Information and the National Institute of Statistics, and were processed using Microsoft Office Excel. No evaluation by an ethics committee was required.
Results: 18,216 cases were studied, determining a HDR of 24.64 cases per 100,000 inhabitants, with a progressive increase during the period. There was a predominance of females and of the 45-64 age group. The average hospital stay was 3.01 days, being longer in the male sex.
Discussion: HDR during the period 2020-2023 registered a progressive increase. This could be caused by the COVID 19 pandemic generating delays in diagnosis. The predominance of the female sex and the range between 45 and 64 years of age could be determined by the increase in risk factors such as obesity and sedentary lifestyle. Finally, the greater hospital stay in men could be caused by late diagnosis. We were able to establish a risk pattern in accordance with the results obtained. This opens the debate on the relevance of early prevention strategies in men.
Keywords: Thyroid neoplasms; Chile; Hospitalization; Epidemiology; Endocrinology.
References
Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer [Internet]. 2021 [citado 3 de junio de 2025];149(5):984–92. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34013533/
Lyu Z, Zhang Y, Sheng C, Huang Y, Zhang Q, Chen K. Global burden of thyroid cancer in 2022: Incidence and mortality estimates from GLOBOCAN. Chin Med J (Engl) [Internet]. 5 de noviembre de 2024;137(21):2567–76. Disponible en: https://journals.lww.com/10.1097/CM9.0000000000003284
Tala H, Domínguez RDJ, Pineda P, Olmos R, Munizaga F, Hidalgo S, et al. Protocolo clínico del cáncer diferenciado de Tiroides. Programa de cáncer del adulto 2020. [citado 22 Mayo 2025]. Disponible en: https://soched.cl/guias/PROTOCOLO-CLINICO-CANCER-DIFERENCIADO-TIROIDES.pdf
Ghossein R, Katabi N, Dogan S, Shaha AR, Tuttle RM, Fagin JA, et al. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology [Internet]. 2024;84(7):1130–8. Disponible en: http://dx.doi.org/10.1111/his.15157
Sapunar Z. J, Ferrer R. P, Sapunar Z. J, Ferrer R. P. Epidemiología del cáncer de tiroides en un Instituto Oncológico. Efecto de las nuevas recomendaciones clínicas. Rev Med Chil [Internet]. 1 de mayo de 2020 [citado 4 de junio de 2025];148(5):573–81. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000500573&lng=es&nrm=iso&tlng=es
Santisteban P. Patogenia molecular del cáncer de tiroides. Rev Cáncer (Madrid) [Internet]. 2019 [citado 5 de junio de 2025];33(6):267-76. Disponible en: https://www.revistarevisionesencancer.com/filesPortalWeb/112/MA-H0108-01.pdf?dIyypbvRutX1JVCLTgCwzNcFQBPZCJpg
Vega-López S, López-Olmedo N, Carriquiry AL, Rodríguez-Ramírez S. Accuracy of the minimum dietary diversity indicator for predicting micronutrient adequacy in Mexican children 1–5 years of age: A pooled analysis of national dietary data. Prev Med. 2025;176:107716. doi:10.1016/j.ypmed.2024.107716.
Pruebas para detectar el cáncer de tiroides | American Cancer Society [Internet]. [citado 4 de junio de 2025]. Disponible en: https://www.cancer.org/es/cancer/tipos/cancer-de-tiroides/deteccion-diagnostico-clasificacion-por-etapas/como-se-diagnostica.html
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, et al. Thyroid Carcinoma, Version 2.2022 NCCN clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network [Internet]. 1 de agosto de 2022 [citado 3 de junio de 2025];20(8):925–51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35948029/
Javidi S, Sadrizadeh S, Sadrizadeh A, Bonakdaran S, Jarahi L. Postoperative complications and long-term outcomes after total and subtotal thyroidectomy: a retrospective study. Sci Rep. 1 de diciembre de 2025;15(1):3705.
Parra-Soto S, Petermann-Rocha F, Martínez-Sanguinetti MA, Leiva-Ordeñez AM, Troncoso-Pantoja C, Ulloa N, et al. Cáncer en Chile y en el mundo: una mirada actual y su futuro escenario epidemiológico. Rev Med Chil [Internet]. 1 de octubre de 2020 [citado 3 de junio de 2025];148(10):1489–95. Disponible en:
Rigollet SS, Oliva PE, Romero PG, Pozo MCJ, Pérez OC, Mebus CI. Marco general del plan nacional del cancer 2022-2027 [Internet]. 2022. [citado 22 de abril de 2025]. Disponible en:
https://leydelcancer.minsal.cl/documentos/Marco-general-del-Plan-Nacional-de-Cancer-2022-2027.pdf
Deng T, Liu Q, Zi H, Guo X, Huang Q, Yang Y, et al. Global trends in thyroid cancer 1990–2021: an analysis based on the GBD 2021. Endocr Relat Cancer [Internet]. 1 de marzo de 2025 [citado 3 de junio de 2025];32(3). Disponible en: https://erc.bioscientifica.com/view/journals/erc/32/3/ERC-24-0297.xml
Douglas EH, Rhoads A, Thomas A, Aloi J, Suhl J, Lycan T, et al. Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016. Thyroid. 1 de diciembre de 2020;30(12):1781–91.
Weeks KS, Kahl AR, Lynch CF, Charlton ME. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014. Cancer. 1 de abril de 2018;124(7):1483–91.
Chen MM, Luu M, Sacks WL, Orloff L, Wallner LP, Clair JMS, et al. Trends in incidence, metastasis, and mortality from thyroid cancer in the USA from 1975 to 2019: a population-based study of age, period, and cohort effects. Lancet Diabetes Endocrinol [Internet]. 1 de marzo de 2025 [citado 3 de junio de 2025];13(3):188–95. Disponible en: https://www.thelancet.com/action/showFullText?pii=S2213858724003103
Jia MJ, Wang S, Li Y, Liu XN, Jiang F, Li HL. Global burden of thyroid cancer among adolescents and young adults, 1990-2021, and projections to 2050: an analysis based on the GBD 2021. Front Endocrinol (Lausanne). 2025;16.
Kwon H, Lee JH, Woo J, Lim W, Moon BI, Paik NS. Efficacy of a clinical pathway for patients with thyroid cancer. Head Neck [Internet]. 1 de septiembre de 2018 [citado 3 de junio de 2025];40(9):1909–16. Disponible en: /doi/pdf/10.1002/hed.25175
Van Dijk SPJ, Coerts HI, Lončar I, Van Kinschot CMJ, von Meyenfeldt EM, Visser WE, et al. Regional collaboration and trends in clinical management of thyroid cancer. Otolaryngol Head Neck Surg [Internet]. 1 de enero de 2024 [citado 3 de junio 2025];170(1):159–68. Available from: https://doi.org/10.1002/ohn.481
Siches I, Vega J, Chomalí M, Yarza B, Estay R, Goyenechea M, et al. El impacto de Covid-19 en el Sistema de Salud y propuestas para la reactivación [Internet]. Santiago de Chile: Colegio Médico de Chile; 2020 [citado 5 junio de 2025]. Disponible en: https://www.colegiomedico.cl/wp-content/uploads/2020/08/reactivacion-sanitaria.pdf
Suteau V, Munier M, Briet C, Rodien P. Sex bias in differentiated thyroid cancer. Int J Mol Sci. 2021;22(23):12992.
Germano A, Schmitt W, Almeida P, Mateus-Marques R, Leite V. Ultrasound requested by general practitioners or for symptoms unrelated to the thyroid gland may explain higher prevalence of thyroid nodules in females. Clin Imaging [Internet]. 1 de julio de 2018 [citado 3 de junio de 2025];50:289–93. Disponible en: https://www.clinicalimaging.org/action/showFullText?pii=S0899707118301062
Correa E, Kimelman F, Aguayo P. Estudio sobre la participación de los padres en el sistema público de salud de Chile: informe final [Internet]. Santiago de Chile: Ministerio de Desarrollo Social; 2012 [citado 2025 Jun 5]. Disponible en: https://www.crececontigo.gob.cl/wp-content/uploads/2015/11/14-Informe-final-Estudio-sobre-la-participacion-de-los-padres-en-el-sistema-publico-de-salud-de-Chile.pdf
Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol [Internet]. 1 de abril de 2021 [citado 3 de junio de 2025];9(4):225–34. Disponible en: https://www.thelancet.com/action/showFullText?pii=S2213858721000279
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Carolina Donoso Diaz, Jorge Casanova Pardo, Simone Chavez Cabrera, Pablo Chandía Serrano, Luis Yaraure Fermin, Bárbara Mena González
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
